Helius Medical Technologies, Inc. (HSDT) Tops Q2 EPS by 15c

Helius Medical Technologies, Inc. (NASDAQ: HSDT) reported Q2 EPS of ($0.97), $0.15 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $119 thousand versus the consensus estimate of $360 thousand.

For earnings history and earnings-related data on Helius Medical Technologies, Inc. (HSDT) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• CVG to join Russell 2000 and Russell 3000 indexes June 26
• Cerebras Q1 EPS miss sends shares down 9% after-hours